Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Carcinoma, Medullary × yeast-CEA vaccine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Triple Negative Breast Neoplasms 2 Colorectal Neoplasms 2 Pancreatic Neoplasms 1 Melanoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Medullary 1

Interventions

vandetanib 10 selpercatinib 5 cabozantinib 4 pralsetinib 2 yeast-CEA vaccine 1 motesanib diphosphate 1 anlotinib 1 Sorafenib 1 Ranitidine 1 Omeprazole 1 Melphalan 1 Calcium Aluminosilicate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01856920 2024-07-09

QUILT-3.006 for Recurrent Medullary Thyroid Cancer

NantCell, Inc.

Phase 2 Completed

35 enrolled 9 charts

Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡